Selling Medicare Supplement vs. Medicare Advantage: Commission, Retention, and Strategy Compared

Med Supp pays higher commissions but MA has faster sales cycles. Here's how to decide — or sell both.

TL;DR

Med Supp pays $270–$704 FYC with 88–92% persistency; MA pays $611 flat with 78–83% persistency. Top producers use a hybrid strategy selling both.

Key Data Points

  • Med Supp 13-month persistency is 88–92% vs 78–83% for Medicare Advantage
  • 2026 CMS Medicare Advantage commission rate is $611 first-year
  • Top Medicare producers use a hybrid Med Supp + MA strategy

Selling Medicare Supplement vs. Medicare Advantage

Every Medicare agent faces this decision: Med Supp, MA, or both? Med Supp first-year commission: $270–$704. MA: $611 flat (2026 CMS rate). Med Supp persistency: 88–92%. MA: 78–83%. Med Supp close rate: 25–35%. MA: 40–55%.

The Hybrid Strategy

Top producers sell both: lead with MA for quick wins during AEP, present Med Supp to healthier clients who qualify, cross-sell ancillaries on every appointment, and use AI quoting to show both options side-by-side.

unLocked CRM runs simultaneous MA and Medigap comparisons in a single presentation.

Med Supp vs. Medicare Advantage Selling

Factor — Med Supp — Medicare Advantage

First-Year Commission — $270–$704 — $611 flat

Persistency (13-mo) — 88–92% — 78–83%

Close Rate — 25–35% — 40–55%

Enrollment Window — Year-round — AEP/OEP/SEP

Frequently Asked Questions

Which pays more: Med Supp or Medicare Advantage?

Med Supp FYC ranges $270–$704 vs MA's $611 per user. Med Supp has higher persistency (88–92% vs 78–83%), making lifetime value higher.

Can you sell both Med Supp and Medicare Advantage?

Yes. Lead with MA for volume during AEP, present Med Supp to healthier clients, cross-sell ancillaries on every appointment.